Croda

Abstract Preservatives are critical for preventing microbial contamination in multi-dose biologics, yet their compatibility with proteins poses a major challenge....

Abstract Macrophages, as cells of the innate immune response, are involved in the pathology of various medical conditions (tumors, intracellular...

Abstract Nanoemulsions are pivotal carriers which are increasingly adopted as carriers for poorly soluble active molecules. This review provides a...

Abstract Background/Objectives: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently...

High purity amino acids for bioprocessing and formulation Amino acids are the fundamental building blocks of proteins and play a...

Abstract Here, we report dissolution of aprepitant from three phospholipid-based amorphous solid dispersions (ASDs), namely binary ASDs containing drug and...

PRESS RELEASE 4 March 2026: Croda successfully launches new Amino Acid range BioXPro™: Croda International Plc (“Croda”) today confirms the successful...

Abstract Colorectal cancer (CRC) continues to be a foremost human health concern globally, with chemotherapy being the cornerstone of the...

In the following article, Croda International shares an exclusive conversation with one of its biologics leaders, Mo Pinto. From his...

Abstract Therapeutic agents approved for the topical treatment of dermatological diseases have diverse physicochemical properties, but they are frequently poorly...